دوره 5، شماره 2 - ( 2-1400 )                   جلد 5 شماره 2 صفحات 21-26 | برگشت به فهرست نسخه ها

XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Saifi A, Taheri N S, Mansourian H R, Mansourian A R. Pharmacological Survey of Graves' Disease: A Mini Review. jcbr. 2021; 5 (2) :21-26
URL: http://jcbr.goums.ac.ir/article-1-312-fa.html
Pharmacological Survey of Graves' Disease: A Mini Review. Journal of Clinical and Basic Research. 1400; 5 (2) :21-26

URL: http://jcbr.goums.ac.ir/article-1-312-fa.html


چکیده:   (83 مشاهده)

Thyroid hormones play a key role indevelopment of most metabolic disease. Toxic multi nodular goiter, toxic adenoma and thyroid autoimmunity are the most common causes of thyrotoxicosis. Graves’ diseaseis an autoimmune thyroid disorder characterized by production of autoantibodies against thyroid-stimulating hormone receptor on the thyroid gland.G raves’ disease-related thyrotoxicosis can be controlled either through medication or surgical and radiotherapy interventions. There are few options for the prevention of thyroid hormones overproduction including antithyroid drugs such as methimazole and propylthiouracil, carbimazole, radioactive iodine as well as thyroidectomy. In this study, the latest pharmacological information on treatment of Graves' disease are reviewed.

     
نوع مقاله: گزارش مورد | موضوع مقاله: علوم پایه پزشکی
دریافت: 1400/3/19 | پذیرش: 1400/1/12 | انتشار: 1400/1/12

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

کلیه حقوق این وب سایت متعلق به Journal of Clinical and Basic Research می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2021 CC BY-NC 4.0 | Journal of Clinical and Basic Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).